Effect of dietary intake of isoflavones on the estrogen and progesterone receptor status of breast cancer

Nutrition and Cancer

Volumn 62, Issue 6, 2010, Pages 765-773

  Zhang, Min ^a   Liu, Xiaojiao ^b   Holman, C D'Arcy J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTROGEN RECEPTOR; GENISTEIN; ISOFLAVONE DERIVATIVE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CHINESE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HISTOPATHOLOGY; HUMAN; INTERVIEW; INTRADUCTAL CARCINOMA; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 77954988073     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605979     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108, 2005.
2. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, and Murray CJ: Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000. BMC Cancer 2, 37, 2002.
3. Shu XO, Jin F, Dai Q, Wen W, Potter JD, et al.: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10, 483-488, 2001. (Pubitemid 32701634)
4. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, et al.: Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center- based prospective study group. J Clin Oncol 26, 1677-1683, 2008.
5. Wu AH, Koh WP, Wang R, Lee HP, and Yu MC: Soy intake and breast cancer risk in Singapore Chinese Health Study. Br J Cancer 99, 196-200, 2008.
6. Trock BJ, Hilakivi-Clarke L, and Clarke R: Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98, 459-471, 2006.
7. Boyapati SM, Shu XO, Ruan ZX, Dai Q, Cai Q, et al.: Soyfood intake and breast cancer survival: a follow-up of the Shanghai Breast Cancer Study. Breast Cancer Res Treat 92, 11-17, 2005.
8. Wu AH, Yu MC, Tseng CC, and Pike MC: Epidemiology of soy exposures and breast cancer risk. Br J Cancer 98, 9-14, 2008.
9. Payne SJ, Bowen RL, Jones JL, and Wells CA: Predictive markers in breast cancer-the present. Histopathology 52, 82-90, 2008.
10. Dunnwald LK, Rossing MA, and Li CI: Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9, R6, 2007.
11. Suzuki T, Matsuo K, Tsunoda N, Hirose K, Hiraki A, et al.: Effect of soybean on breast cancer according to receptor status: a case-control study in Japan. Int J Cancer 123, 1674-1680, 2008.
12. Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S, et al.: Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 138, 938-945,2008.
13. Touillaud MS, Pillow PC, Jakovljevic J, Bondy ML, Singletary SE, et al.: Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 51, 162-169, 2005.
14. Ha TC, Lyons-Wall PM, Moore DE, Tattam BN, Boyages J, et al.: Phytoestrogens and indicators of breast cancer prognosis. Nutr Cancer 56, 3-10, 2006.
15. Sarkar FH and Li Y: Soy isoflavones and cancer prevention. Cancer Invest 21, 744-757, 2003.
16. Zava DT, Dollbaum CM, and Blen M: Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 217, 369-378, 1998.
17. Franke AA, Custer LJ, Wang W, and Shi CY: HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217, 263-273, 1998.
18. Zhang M, Yang ZY, Binns CW, and Lee AH: Diet and ovarian cancer risk: a case-control study in China. Brit J Cancer 86, 712-717, 2002. (Pubitemid 34250811)
19. Zhang M, Binns CW, and Lee AH: A quantitative food frequency questionnaire for women in southeast China: development and reproducibility. Asia Pac J Public Health 17, 29-35, 2005.
20. Whitemore AS, Wu-Willians AH, Lee M, Lee M, Zheng S, et al.: Diet, physical activity and colorectal cancer among Chinese in North American and China. J Natl Cancer Inst 82, 915-926, 1990.
21. Institute of Nutrition and Food Hygiene, Chinese Academic of Preventive Medicine: Food Composition Table (National Representative Values), 1st ed. Beijing, China: People's Health Press, 1999.
22. United States Department of Agriculture: USDA Database for the Isoflavone Content of Selected Foods, 2008. Accessed January 15, 2009 at http://www.ars.usda.gov/nutrientdata/isoflav
23. Xu X, Duncan AM, Merz BE, and Kurzer MS: Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomark Prev 7, 1101-1108, 1998. (Pubitemid 29001666)
24. Lu LJ, Anderson KE, Grady JJ, Kohen F, and Nagamani M: Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. CancerRes 60, 4112-4121, 2000.
25. Adlercreutz CH, Goldin BR, Gorbach SL, Hockerstedt KA, Watanabe S, et al.: Soybean phytoestrogen intake and cancer risk. J Nutr 125, 757S-770S, 1995.
26. Kumar NB, Cantor A, Allen K, Riccardi D, and Cox CE: The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer 94, 1166-1174, 2002.
27. Kramer F, Johnson IT, Doleman JF, and Lund EK: A comparison of the effects of soya isoflavonoids and fish oil on cell proliferation, apoptosis and the expression of oestrogen receptors alpha and beta in the mammary gland and colon of the rat. Br J Nutr 12, 1-8, 2008.
28. Staar S, Richter DU, Makovitzky J, Briese V, and Bergemann C: Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ERalpha- and ERbeta-mRNA and protein expression. Anticancer Res 25, 1713-1718, 2005.
29. Yuen YM and Leung LK: Genistein and daidzein induced apoA-1 transactivation in hepG2 cells expressing oestrogen receptor-alpha. Br J Nutr 99, 1007-1012, 2008.
30. Ge KY, Zhai FY, Yan HC, Cheng L, Wang Q, et al.: The dietary and nutritional status of Chinese populations in 1990s. ACTA Nutrimenta Sinica 17, 123-134, 1995.
31. Wu AH, Yu MC, Tseng CC, Twaddle NC, and Doerge DR: Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian- American women in Los Angeles County. Carcinogenesis 25, 77-81,2004.
32. Verkasalo PK, Appleby PN, Allen NE, Davey G, Adlercreutz H, et al.: Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition). Br J Nutr 86, 415-421, 2001.
33. Maskarinec G, Singh S, Meng L, and Franke AA: Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomark Prev 7, 613-619, 1998.
34. Horn-Ross PL, Barnes S, Lee M, Coward L, Mandel JE, et al.: Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control 11, 289-298, 2000.